SCHEMBL10288334

SCHEMBL10288334

COC(=O)c1c(C(=O)c2ccccc2)sc(N2CCOCC2)c1C(=O)OC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 8/20 0.50
▸ ALOX5 P09917 1/20 0.50
▸ KMT2A Q03164 2/20 0.49
▸ HTT P42858 2/20 0.49
▸ L3MBTL1 Q9Y468 2/20 0.49
▸ MEN1 O00255 1/20 0.49
▸ LMNA P02545 1/20 0.49
▸ HSD17B10 Q99714 1/20 0.45
▸ POLB P06746 3/20 0.44
▸ MAPT P10636 3/20 0.44
▸ MRGPRX4 Q96LA9 1/20 0.44
▸ KDM4E B2RXH2 1/20 0.44
▸ MAPK1 P28482 1/20 0.44
▸ CYP1A2 P05177 1/20 0.43
▸ CYP3A4 P08684 1/20 0.43
▸ GAA P10253 1/20 0.43
▸ CYP2C9 P11712 1/20 0.43
▸ CYP2C19 P33261 1/20 0.43
▸ PRKDC P78527 1/20 0.43
▸ HPGD P15428 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10298239 0.91 ALDH1A1 (0.47) ALDH1A1ALOX5KMT2AHTTL3MBTL1
SCHEMBL10288080 0.80 HSD17B10 (0.53) ALDH1A1HSD17B10MAPTKDM4EMAPK1
SCHEMBL10288078 0.80 ALDH1A1 (0.51) ALDH1A1KMT2AMEN1HSD17B10POLB
SCHEMBL17237505 0.74 PIK3CA (0.51) ALDH1A1ALOX5HTTL3MBTL1LMNA
SCHEMBL4487982 0.74 ALDH1A1 (0.56) ALDH1A1ALOX5KMT2AHTTMEN1
SCHEMBL10298243 0.73 HSD17B10 (0.51) ALDH1A1KMT2AMEN1LMNAHSD17B10
SCHEMBL3121821 0.73 PIK3CA (0.44) ALDH1A1KMT2AL3MBTL1MEN1LMNA
SCHEMBL10288077 0.72 ALDH1A1 (0.44) ALDH1A1KMT2AMEN1HSD17B10POLB
SCHEMBL10298244 0.71 ALDH1A1 (0.44) ALDH1A1KMT2AHTTMEN1HSD17B10
SCHEMBL17237507 0.71 ALDH1A1 (0.50) ALDH1A1ALOX5KMT2AHTTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150175563-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARM INC (US) 2015-06-25 — — US disclosed
US-20150175593-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARM INC (US) 2015-06-25 — — US disclosed
US-8796268-B2 Heteroaryls and uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2014-08-05 — — US disclosed
US-8796271-B2 Heteroaryls and uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2014-08-05 — — US disclosed
US-20120178723-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2012-07-12 — — US disclosed
US-20120172345-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2012-07-05 — — US disclosed
WO-2012021696-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2012-02-16 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120172345-A1 HETEROARYLS AND USES THEREOF PIK3R1, PIK3R2, PIK3R3 ALDH1A1 429/4885ALOX5 524/4885KMT2A 1647/4885
US-20150175563-A1 HETEROARYLS AND USES THEREOF PIK3R1, PIK3R2, PIK3R3 ALDH1A1 429/4885ALOX5 524/4885KMT2A 1647/4885
US-20120178723-A1 HETEROARYLS AND USES THEREOF PIK3R1, PIK3R2, PIK3R3 ALDH1A1 395/4885ALOX5 302/4885KMT2A 1460/4885
US-20150175593-A1 HETEROARYLS AND USES THEREOF PIK3R1, PIK3R2, PIK3R3 ALDH1A1 395/4885ALOX5 302/4885KMT2A 1460/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback